Cisatracurium;Cisatracurio

Revista Espanola de Anestesiologia y Reanimacion

Volumn 45, Issue 6, 1998, Pages 242-247

  Ortiz, J R ^a   Percaz, J A ^a   Carrascosa, F ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Cisatracurium; Muscle relaxants; Nondepolarizing neuromuscular blockade

Indexed keywords

ATRACURIUM; CISATRACURIUM; HISTAMINE; LAUDANOSINE; MUSCLE RELAXANT AGENT; NEUROMUSCULAR BLOCKING AGENT; ROCURONIUM; STEROID;

AGED; ANESTHETIC RECOVERY; CARDIOVASCULAR DISEASE; DOSE RESPONSE; DRUG HYDROLYSIS; DRUG INDICATION; DRUG METABOLISM; DRUG POTENCY; ENDOTRACHEAL INTUBATION; HEMODYNAMICS; HISTAMINE RELEASE; HUMAN; INTENSIVE CARE; KIDNEY DISEASE; KIDNEY METABOLISM; LIVER DISEASE; NERVE STIMULATION; OPERATION DURATION; PEDIATRIC ANESTHESIA; RACEMIC MIXTURE; REVIEW;

AGED; ATRACURIUM; CHILD; CHILD, PRESCHOOL; HUMANS; INTENSIVE CARE; KIDNEY FAILURE, CHRONIC; LIVER FAILURE; NEUROMUSCULAR DEPOLARIZING AGENTS;

EID: 0031823264     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Savarese JJ, Wastila WB. The future of the benzylisoquinolinium relaxants. Acta Anesthesiol Scand 1995; 106 (Supl): 91-93.
2. Diefenbach C, Nigrovic V, Mellinghoff H, Buzello W. Muscle relaxants. New substances and neuromuscular monitoring. Anaesthesist 1997; 46: 3-13.
3. Mirakhur RK, NcCourt KC, Kumar N. Acta Anacsthesiol Belg 1997; 48: 29-34.
4. Nigrovic V, Diefenbach C, Mellinghoff H. Esters and stereoisoniers. Anaesthesist 1997; 46: 282-286.
5. Wastila WB, Maehr RB, Turner GL, Hill DA, Savarese JJ. Comparative pharmacology of cisatracurium (51W89), atracurium and five isomers in cats. Anesthesiology 1996; 85: 169-177.
6. Trissel LA, Martínez JF, Gilbert DL Jr. Compatibility of cisatracurium besylate with selected drugs during Y-site administration. Am J Health Syst Pharm 1997; 54: 1.735-1.741.
7. Schmith VD, Fielder-Kelly J, Phillips L, Grasela TH Jr. Prospective use of population pharmacokinetics/pharmacodynamics in the development of cisatracurium. Pharm Res 1997; 14: 91-97.
8. Welch RM, Brown A, Ravitch J, Dahl R. The in vitro degradation of cisatracium, the R, cis-R'isomer of atracurium, in human and rat plasma Clin Pharmacol Ther 1995; 58: 132-142.
9. Dear GJ, Harrelson JC, Jones AE, Johnson TE, Pleasance S. Identification of urinary and biliary conjugated metabolites of the neuromuseular blocker 51W89 by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 1995; 9: 1.457-1.464.
10. Kisor DF, Schmith VD, Wargin WA, Lien CA, Ornstein E, Cook DR. Importance of organ-independent elimination of cisatracurium. Anesth Analg 1996; 83: 1.065-1.071.
11. Bergeron L, Pharm B, Varin F, Berrill A, Kahwaji R, Bevan D. Kinetics and dynamics of cisatracurium at 3 doses in anaesthetized patients. Anesthesiology 1996; 85: 324.
12. 2O anesthesia. Anesthesiology 1996; 85: 325.
13. Schmith VD, Fielder-Kefly J, Phillips L, Grasela TH Jr. Dose proporcionality of cisatracurium. J Clin Pharmacol 1997; 37: 625-629.
14. Lien CA, Schmith VD, Belmont MR, Abalos A, Kisor DF, Savarese JJ. Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1996; 84: 300-308.
15. Mellinghoff H, Diefenbach C. The clinical pharmacology of cisatracurium. Anesthesist 1997; 46: 481-485.
16. Bryson HM, Faulds D. Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice. Drug 1997; 53: 848-866.
17. Belmont MR, Lien CA, Quessy S, Abou-Donia MM, Abalos A, Eppich L et al. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995; 82: 1.139-1.145.
18. Berrill A, Kahwaji R, Bevan D. Pharmacodynamic half-life of cisatracurium. Anesthesiology 1996; 85: 833.
19. 2-opioid anesthesia. Anesth Analg 1996; 83: 823-829.
20. Mellinghoff H, Radbruch L, Diefenbach C, Buzello W. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion. Anesth Analg 1996; 83: 1.072-1.075.
21. Lien CA, Pavlin EG, Belmont MR, Visco E, Abalos A, McClung C. Evaluation of intubation at 60 seconds following 0.4 mg/kg cisatracurium or 0.9 mg/kg rocuronium Anesthesiology 1996; 85: 830.
22. Clendenen SR. Anaphylactic reaction after cisatracurium. Anesthesiology 1997; 87: 690-692.
23. Doenicke A, Soukup J, Hoernecke R, Moss J. The lack of histamine release with cisatracurium: a double-blind comparison with vecuronium. Anesth Analg 1997; 84: 623-628.
24. Soukup J, Doenicke A, Hoernecke R, Qass J. Cisatracurium -is the stereoisomer an "ideal" relaxant? Histamine liberation and tryptase determination after bolus administration of cisatracurium: a comparison with vecuronium. Anaesthesist 1997; 46: 486-491.
25. Lien CA, Belmont MR, Abalos A, Eppich L, Quessy S, Abou-Donia MM et al. The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995; 82: 1.131-1.138.
26. Reich DL, Konstadt SN, Van-Aken H, Murlier J, Viby-Mogensen J, DePerio M et al. A three-center study of the cardiovascular effects of cisatracurium in patients with coronary artery disease. Anesthesiology 1997; 85: 834.
27. Meretoja OA, Taivainen T, Wirtavuori K. Pharmacodynamic effects of 51W89, an isomer of atracurium, in children during halothane anaesthesia. Br J Anaesth 1995; 74: 6-11.
28. Meretoja OA, Taivainen T, Wirtavuon K Cisatracurium during halothane and balanced anesthesia in children. Paediatr Anaesth 1996; 6: 373-378.
29. O'Neill BL, Foley EP. The neuromuscular blocking effects of cisatracurium in children during sevoflurane anesthesia. Anesthesiology 1997; 85: 1.058.
30. Brandom BW, Westman HR. Effects of 0.86 mg/kg cisatracurium in an infant. Anesthesiology 1996; 85: 688-689.
31. Ornstein E, Lien CA, Matteo RS, Ostapkovich ND, Díaz J, Wolf KB. Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients. Anesthesiology 1996; 84: 520-525.
32. Sorooshian SS, Stafford MA, Eastvvood NB, Boyd AH, Hull CJ, Wright PM. Pharmacoaneitics and pharmacodynamics of cisatracurium in young and elderly adult patients. Anesthesiology 1996; 84: 1.083-1.091.
33. Eastwood NB, Boyd AH, Parker CJ, Hunter JM. Phamacokinetics of IR-cis FR-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure. Br J Anaesth 1995; 75: 431-435
34. De Wolf AM, Freeman JA, Scott VL, Tullock W, Smith DA, Kisor DF et al. Pharmacokinetis and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation. Br J Anaesth 1996; 76: 624-628.
35. Boyd AH, Eastwood NB, Parker CJ, Hunter JM. Pharmacodynamics of the IR cis-1'R cis isomer of atracurium (51W89) in health and chronic renal failure. Br J Anaesth 1995; 74: 400-404.
36. Hunter JM, Eastwood NB, Boyd AH, Parker CJ. Pharmacokinetics of 51W89: preliminary data. Acta Anaesthesiol Scand 1995; 106 (Supl): 94-97.
37. Konstadt SN, Reich DL, Stanley TE-3rd, DePerio M, Chuey C, Schwartzbach C et al. A two-center comparison of the cardiovascular effects of cisatracurium (Nimbex) and vecuronium in patients with coronary artery disease. Anesth Analg 1995; 81: 1.010-1.014.
38. Newman PJ, Quinn AC, Grounds RM, Hunter JM, Boyd AH, Eastwood NB et al. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients. Crit Care Med 1997; 25: 1.139-1.142.
39. Pearson AJ, Harper NJ, Pollard BJ. The infusion requirements and recovery characteristics of cisatracurium or atracurium in intensive care patients. Intens Care Med 1996; 22: 694-698.
40. Boyd AH, Eastwood NB, Parker CJ, Hunter JM. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. Br J Anaesth 1996; 76: 382-388.
41. Prielipp RC, Coursin DB, Scuderi PE, Bowton DL, Ford SR, Cardenas VJ Jr et al. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 1995; 81: 3-12.